Publications (27 results)
Please use discretion when following external links; Assaypro cannot guarantee the validity and security of all citation links provided.* Hu Y et al. (2021) Distinct patterns of apolipoprotein C-I, C-II, and C-III isoforms are associated with markers of Alzheimer's disease. J Lipid Res. 62:100014.
* Shieh YT et al. (2020) Cyclodextrin?micellar electrokinetic chromatography of apolipoproteins on human very low?density lipoprotein. Electrophoresis. 41(15):1333-1343.
* Sandin A et al. (2020) Human apolipoprotein CIII levels; evaluation of three assay methods. Scandinavian Journal of Clinical and Laboratory Investigation. Scand J Clin Lab Invest. 80(3):230-235
* Wonner R et al. (2018) Effects of acute exercise on monocyte subpopulations in metabolic syndrome patients. Cytometry B Clin Cytom. 94(4):596-605.
* Colombo M et al. (2018) Apolipoprotein CIII and N-terminal prohormone b-type natriuretic peptide as independent predictors for cardiovascular disease in type 2 diabetes. Atherosclerosis.274:182-190
* Allaire J et al. (2018) High-Dose DHA Has More Profound Effects on LDL-Related Features Than High-Dose EPA: The ComparED Study. J Clin Endocrinol Metab. 103(8):2909-2917.
* Watts GF (2017) Factorial Effects of Evolocumab and Atorvastatin on Lipoprotein Metabolism. Circulation. 135(4):338-351.
* Tikka A et al. (2017) ANGPTL3 serum concentration and rare genetic variants in Finnish population. Scand J Clin Lab Invest. 77(8):601-609.
* Tikka A (2017) CHARACTERIZATION OF ANGPTL3 DEFICIENCY AND MOLECULAR MECHANISMS OF ANGPTL3 DEFICIENCYINDUCED HYPOLIPIDEMIA. University of Helsinki.
* Hyysalo J (2017) Prevalence and Genetics of Non-Alcoholic Fatty Liver Disease. University of Helsinki.
* Sandin A et al. (2015) QUANTITATIVE DETERMINATION OF PROTEIN APOCIII IN SERUM: COMPARISON OFTHREE ASSAY METHODS. Clin. Chem Lab Med 2015:53, Special Suppl, pp S248
* Chan DC et al. (2015) Inter-relationships between proprotein convertase subtilisin/kexin type 9, apolipoprotein C-III and plasma apolipoprotein B-48 transport in obese subjects: a stable isotope study in the postprandial state. Clin Sci (Lond). 128(6):379-85.
* Bridge SH et al.(2015) PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: Evidence for genotype-specific regulation of lipoprotein metabolism. J Hepatol. 2015 Apr;62(4):763-70.
* Richard C et al. (2014) Effect of Mediterranean Diet With and Without Weight Loss on Apolipoprotein B100 Metabolism in Men With Metabolic Syndrome. Arterioscler Thromb Vasc Biol. 34:433-438
* Riwanto M et al. (2013) Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling. Circulation. 127(8):891-904
* Pi B and Bilello J (2013) Biomarkers for monitoring treatment of neuropsychiatric diseases. Patent application EP20110846638
* Nichols SKF et al. (2013) Impaired lipid transport in gestational diabetes mellitus. Journal of Diabetes Research & Clinical Metabolism. doi: 10.724/2050-0866-2-22
* Lee JH et al. (2013) Characterization of the fetal blood transcriptome and proteome in maternal anti-fetal rejection: evidence of a distinct and novel type of human fetal systemic inflammatory response. Am J Reprod Immunol. 2013 Oct;70(4):265-84. doi: 10.1111/aji.12142. Epub 2013 Jul 30
* Huang ZH et al. (2013) Apo E Derived from Adipose Tissue Does Not Suppress Atherosclerosis or Correct Hyperlipidemia in EKO Mice. J. Lipid Res. 54(1):202-213.
* Flood-Nichols SK et al. (2013) Longitudinal Analysis of Maternal Plasma Apolipoproteins in Pregnancy: A Targeted Proteomics Approach. Molecular & Cellular Proteomics 12.1
* Sakamoto H et al. (2012) An Apolipoprotein CIII-Derived Peptide, Hatktak, Activates Macromolecular Activators of Phagocytosis from Platelets (MAPPs). Lipoproteins - Role in Health and Diseases. Chapter 31. p.721-740
* Pi B et al. (2012) Biomarkers for monitoring treatment of neuropsychiatric diseases. Patent application number: US20120178118 A1
* Hyysalo J (2012) Genetic variation in PNPLA3 but not APOC3 influences liver fat in non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2012 May;27(5):951-956
* Wang Y et al. (2011) Development of a Sensitive ELISA to Quantify Apolipoprotein CIII in Non-human Primate Serum. J Lipid Res. 52(6):1265-1271
* Papakostas GI (2011) Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a Pilot and Replication Study. Mol Psychiatry 18(3):332-9.
* Hansen JB et al. (2011) The Apolipoprotein C-I Content of Very-Low-Density Lipoproteins Is Associated with Fasting Triglycerides, Postprandial Lipemia, and Carotid Atherosclerosis. J Lipids. 2011:271062.
* Flood-Nichols SK et al. (2011) Elevated Ratio of Maternal Plasma ApoCIII to ApoCII in Preeclampsia. Reprod Sci. 18(5):493-502.
